Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

NCT01135914 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: ranibizumab
PROCEDURE: Laser

Sponsor

Novartis Pharmaceuticals